Research map: The ‘Slow Burn’ Phenotype: How Relative Caloric Intake Reveals Hidden Cardiovascular Risk Beyond BMI

Back to the article

Papers in this map

  1. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age · Cathie L. M. Sudlow · 2015 · 13948 citations · Cited by this paper
  2. Economic Impact of Multidisciplinary Pre‐operative Diabetes Care Versus Usual Care in Adults Undergoing Elective Non‐cardiac Surgery in Australia: A Trial‐Based Analysis · 2026 · Related
  3. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population · Giorgio Bedogni · 2006 · 3178 citations · Cited by this paper
  4. Feasibility of Decentralised Response‐Guided Albuminuria Monitoring to Optimise Empagliflozin and Finerenone Therapy in Type 2 Diabetes and Chronic Kidney Disease · 2026 · Related
  5. A multisociety Delphi consensus statement on new fatty liver disease nomenclature · Mary Eugenia Rinella · 2023 · 3032 citations · Cited by this paper
  6. Metformin Ameliorates Diabetes‐Associated Cognitive Dysfunction via p53/Parkin‐Mediated Mitophagy · 2026 · Related
  7. Definition and diagnostic criteria of clinical obesity · Francesco Rubino · 2025 · 1676 citations · Cited by this paper
  8. Trends and Prevalence of Undiagnosed Dysglycemia Among Reproductive‐Age Women in the United States · 2026 · Related
  9. Critical evaluation of energy intake using the Goldberg cut-off for energy intake:basal metabolic rate. A practical guide to its calculation, use and limitations · AE Black · 2000 · 1498 citations · Cited by this paper
  10. Beyond Glycaemia: Fear of Hypoglycaemia, Cognition and Functional Mobility After Advanced Hybrid Closed‐Loop Therapy in Older Adults With Type 1 Diabetes: A Prespecified Secondary Analysis of a Randomised, Single‐Centre Study · 2026 · Related
  11. What makes UK Biobank special? · Rory Collins · 2012 · 1216 citations · Cited by this paper
  12. Diagnostic Yield of Structured Cushing Syndrome Evaluation in Treatment‐Resistant Non‐Diabetic Obesity: A Retrospective Pilot Study · 2026 · Related
  13. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial · Ania M. Jastreboff · 2023 · 1110 citations · Cited by this paper
  14. Exercise Snacks Are Feasible to Perform in the Real World and Improve Physical Capacity for Adults Living With Non‐Insulin Treated Type 2 Diabetes: A Randomised Trial · 2026 · Related
  15. An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases · Andrew Elagizi · 2018 · 728 citations · Cited by this paper
  16. Real‐World Effectiveness and Safety of Finerenone in People With Type 2 Diabetes and Chronic Kidney Disease: A Spanish Multicentre Retrospective Observational Study ( MEDFINE ‐ RWD ) · 2026 · Related
  17. Sarcopenia and Cardiovascular Diseases · Abdulla A. Damluji · 2023 · 641 citations · Cited by this paper
  18. Sodium Butyrate Attenuates Renal Fibrosis by Regulating Glycolysis and Histone H4K12 Lactylation in Diabetic Kidney Disease · 2026 · Related
  19. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation · Francisco López-Jiménez · 2022 · 368 citations · Cited by this paper
  20. Dietary fat intake and risk of cardiovascular disease and all-cause mortality in a population at high risk of cardiovascular disease · Marta Guasch‐Ferré · 2015 · 316 citations · Cited by this paper
  21. Updates on obesity and the obesity paradox in cardiovascular diseases · Austin W. Tutor · 2022 · 304 citations · Cited by this paper
  22. Risk of Developing Diabetes and Cardiovascular Disease in Metabolically Unhealthy Normal-Weight and Metabolically Healthy Obese Individuals · KoKo Aung · 2013 · 267 citations · Cited by this paper
  23. Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications · Matthias Bernd Schulze · 2024 · 163 citations · Cited by this paper
  24. Dietary Fiber Intake Is Associated with Reduced Risk of Mortality from Cardiovascular Disease among Japanese Men and Women , , · Ehab S. Eshak · 2010 · 161 citations · Cited by this paper
  25. Associations between dietary patterns and the incidence of total and fatal cardiovascular disease and all-cause mortality in 116,806 individuals from the UK Biobank: a prospective cohort study · Min Gao · 2021 · 112 citations · Cited by this paper
  26. Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD · Vlad Ratziu · 2023 · 112 citations · Cited by this paper
  27. Thrift: a guide to thrifty genes, thrifty phenotypes and thrifty norms · Jonathan C. K. Wells · 2009 · 97 citations · Cited by this paper
  28. Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications · Xuan Trong Truong · 2025 · 75 citations · Cited by this paper
  29. Effect of Sarcopenia and Body Shape on Cardiovascular Disease According to Obesity Phenotypes · Hyun-Woong Cho · 2020 · 59 citations · Cited by this paper
  30. Association of Body Mass Index with the Risk of Incident Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality: A Community-Based Prospective Study · Ji Cheol Bae · 2020 · 23 citations · Cited by this paper
  31. Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank · Tae Seop Lim · 2025 · 23 citations · Cited by this paper
  32. Exercise, Exerkines, and Sarcopenia · Hye Soo Chung · 2026 · 8 citations · Cited by this paper

Source: OpenAlex (CC0)